breast neoplasms

Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Tanja Stüber, Razieh Monjezi, Lars Wallstabe, Johanna Kühnemundt, Sarah Louise Nietzer, Gudrun Dandekar, Achim Wöckel, Hermann Einsele, Jörg Wischhusen, Michael Hudecek

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000676; DOI: 10.1136/jitc-2020-000676
Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8⁺ T-cell functionality
Seyedeh-Raheleh Niavarani, Christine Lawson, Marie Boudaud, Camille Simard, Lee-Hwa Tai

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000465; DOI: 10.1136/jitc-2019-000465
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer
Ami N Shah, Lisa Flaum, Irene Helenowski, Cesar A Santa-Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William Gradishar

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000173; DOI: 10.1136/jitc-2019-000173

Main menu